Docetaxel 13-Oxo impurity - Request Quote
Docetaxel 13-Oxo impurity
| SZ CAT No: | SZ-D031041 |
| CAS No | NA |
| Mol.F. | C35H36Cl6O14 |
| Mol.Wt. | 893.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Docetaxel 13-Oxo impurity is chemically (2aR,4S,4aS,6R,12S,12bS)-12b-acetoxy-11-hydroxy-4a,8,13,13-tetramethyl-5,9-dioxo-4,6-bis(((2,2,2-trichloroethoxy)carbonyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. Docetaxel 13-Oxo impurity is supplied with detailed characterization data compliant with regulatory guideline. Docetaxel 13-Oxo impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Docetaxel.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Docetaxel 13-Oxo impurity
Purchase Docetaxel 13-Oxo impurity
Docetaxel 13-Oxo impurity suppliers
Docetaxel 13-Oxo impurity manufacturers
Docetaxel 13-Oxo impurity price
Order Docetaxel 13-Oxo impurity
Enquire Docetaxel 13-Oxo impurity
Docetaxel 13-Oxo impurity cost
Docetaxel 13-Oxo impurity Supplier
Docetaxel 13-Oxo impurity Distributor
Docetaxel 13-Oxo impurity for Method Validation
Docetaxel Reference Standard
Docetaxel 13-Oxo impurity for ANDA Filing
Docetaxel 13-Oxo impurity for Forced Degradation Studies
Docetaxel 13-Oxo impurity Identification Standards
Docetaxel 13-Oxo impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.